Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.31612 | 95 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.65586 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.28575 | 94 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.88354 | 96 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.62848 | 95 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.44796 | 96 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.35825 | 95 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.2421 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.22834 | 94 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.21407 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.36838 | 95 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.40883 | 95 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.56795 | 95 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.38172 | 95 |